Skip to main content
Premium Trial:

Request an Annual Quote

Migrations: Jan 23, 2009

Premium

Genentech this week announced that Jennifer Doudna has been named vice president of discovery research.

In this newly created position, Doudna will oversee the departments of protein chemistry and structural biology. She will be a member of the small molecule drug discovery senior leadership team and will participate in therapeutic RNA discovery efforts. Doudna will report to Richard Scheller, executive vice president of research and chief scientific officer.

Doudna was previously a professor in the department of molecular and cell biology and the department of chemistry, as well as a Howard Hughes Medical Institute Investigator at the University of California, Berkeley. Prior to UC Berkeley, Doudna was Henry Ford II Professor in the department of molecular biophysics and biochemistry at Yale University.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.